Abstract
It gives me great pleasure to welcome you to the September issue of the JCU.
I very much hope that you all had an excellent summer filled with amazement at England’s poor show in the Euro 2016 tournament, a somewhat better fairing at the Rio Olympics, an excellent showing at the home of tennis and an almost predictable cricket test series against Pakistan. After all this excitement, coupled with political earthquakes on both sides of the Atlantic, I trust we are all now raring to get back into the swing of all things urological.
This issue has the full spectrum of offerings from original articles and case reports to CME, review articles and a point of technique, not forgetting of course the latest in our series of clinical research toolkits, on this occasion focussing on writing a literature review and more than worthy of inclusion and reading time.
The investigation of haematuria is a constantly evolving conundrum, with the literature awash with various grades of evidence and recommendations. This, along with the now regular NHS ‘blood in pee’ campaign, makes the review by Wong in this issue all the more relevant for all of us and it is a privilege to be able to publish this in the JCU.
I am especially grateful also to Messers Madaan and Reekhaye for their excellent review of NICE prostate cancer quality standards, which will help all units to meaningfully audit their care delivery against evidence-based standards.
It is articles such as these and the multitude of other excellent quality articles that ensure the ongoing success of the JCU and I am grateful to you all for continuing to submit your work. Many of you will know that the JCU has now submitted an application to Medline and we are currently awaiting their decision, which we anticipate receiving towards the end of the year. Huge thanks go to SAGE, BAUS and the JCU Editorial board for their enormous effort and commitment that this application demanded.
Remaining with SAGE, I would like to welcome Emily Kent to the team who joins as Assistant Editor of the JCU, having replaced Clare Legg who left earlier this year.
As I leave you to devour the academic excellence of this issue of your journal, spare a thought for the impact of Brexit on urological care within the UK and let us strive to maintain the strong and fruitful bond we all enjoy with our friends and colleagues in Europe. Let us hope Urexit doesn’t become the next fictional utterance from Dr Seuss!